Ascendis Pharma A/S (NASDAQ:ASND) Q2 2025 Earnings Call Transcript August 9, 2025
Operator: Good day, and thank you for standing by. Welcome to the Q2 2025 Ascendis Pharma Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker today, Scott Smith, Ascendis Pharma’s CFO. Please go ahead.
Scott T. Smith: Thank you so much, operator. And thank you, everyone, for joining our...
